Multifocal Central Serous Chorioretinopathy Associated with Steroids in a Patient with Myasthenia Gravis

Abstract

We present a case of bilateral multifocal central serous chorioretinopathy in a 40-year-old male who suffered from myasthenia gravis and was receiving oral prednisolone. Due to the severity of the underlying disease, it was not possible to reduce the corticosteroid dose. After initial unsuccessful treatment with an intravitreal injection of ranibizumab, low-fluence photodynamic therapy was performed, followed by gradual tapering of the corticosteroids. Visual acuity improved significantly in both eyes. Different therapeutic approaches are discussed.

Keywords

• Low-fluence photodynamic therapy
• Ranibizumab
• Anti-vascular endothelial growth factor
• Subretinal fibrin
• Central serous chorioretinopathy treatment